NAPRT and glioblastoma: The 3C6D2 antibody detects full length NAPRT in most cell lines with the exception of H460 (non-small cell lung), H929 (multiple myeloma), HT1080 (osteosarcoma), U251MG (glioblastoma) and MIA PaCa-2 (pancreatic) cells.